Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: A 9-year single institute experience in the northern region of Thailand
Background: Osteosarcoma is the most common primary bone tumor in childhood and adolescence. Carboplatin, a platinum-derived agent, is used as neoadjuvant chemotherapy for pediatric osteosarcoma because of its anti-tumor activity and had low toxicity as compared to cisplatin. Objective: To determine...
محفوظ في:
المؤلفون الرئيسيون: | Worawut Choeyprasert, Rungrote Natesirinilkul, Pimlak Charoenkwan, Somjai Sittipreechacharn |
---|---|
التنسيق: | دورية |
منشور في: |
2018
|
الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877637233&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/48213 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
المؤسسة: | Chiang Mai University |
مواد مشابهة
-
Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: A 9-year single institute experience in the northern region of Thailand
بواسطة: Worawut Choeyprasert, وآخرون
منشور في: (2018) -
Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: A 9-year single institute experience in the northern region of Thailand
بواسطة: Choeyprasert W., وآخرون
منشور في: (2014) -
A randomized, open-labeled, prospective controlled study to assess the efficacy of frontline empirical intravenous piperacillin/tazobactam monotherapy in comparison with ceftazidime plus amikacin for febrile neutropenia in pediatric oncology patients
بواسطة: Ruchirek Kamonrattana, وآخرون
منشور في: (2020) -
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: The role of high-dose methotrexate (HDMTX) in a single institute experience
بواسطة: Worawut Choeyprasert, وآخرون
منشور في: (2018) -
Adverse effects of imatinib in children with chronic myelogenous leukemia
بواسطة: Worawut Choeyprasert, وآخرون
منشور في: (2018)